Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Learn practical ways to reduce expenses for home savings. These tips will help you save more money towards your dream home.
18,891 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
As AI reshapes cybersecurity, PANW has surged in months past. This guide explains why the stock may pause, what to wa...
As Netflix faces slowing growth, the question on investors' minds is simple: could the streamer be about to buy somet...
Amid slower housing demand and higher costs, regional and mid-sized builders are leaning on flexible financing to sus...
As AI investment surges, the real cash flow winners are the hardware and infrastructure suppliers. Analysts say forge...
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
When a Planet Labs CEO sells shares, investors take note. This article breaks down what the move could signal, how to...
When a uranium energy stock pops, investors pause to ask what changed and whether the rally can last. This guide brea...
Cyclops, a Miami-based payments infrastructure startup, closed a $20 million Series A to accelerate settlement speeds...
Microsoft stock has slipped in 2026, but a strong earnings report could ignite a rebound. This guide breaks down what...
A veteran investor casts Broadcom as a core AI winner, arguing durable AI demand and strategic partnerships could kee...
A Sea Limited executive sold $4.4 million in stock but remains one of the company’s biggest stakeholders. This piece ...